BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 26603174)

  • 21. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
    Poravuth Y; Socheat D; Rueangweerayut R; Uthaisin C; Pyae Phyo A; Valecha N; Rao BH; Tjitra E; Purnama A; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
    PLoS One; 2011 Jan; 6(1):e14501. PubMed ID: 21267072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.
    Gargano N; Ubben D; Tommasini S; Bacchieri A; Corsi M; Bhattacharyya PC; Rao BH; Dubashi N; Dev V; Ghosh SK; Kumar A; Srivastava B; Valecha N
    Malar J; 2012 Jul; 11():233. PubMed ID: 22818552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of two artemisinin-based combinations for the treatment of malaria in pregnancy in India: a randomized controlled trial.
    Anvikar AR; Kuepfer I; Mishra V; Bruce J; Arya T; Mishra DR; Mohanty S; Mohanty R; Srivastava B; Sharma S; Mishra N; Greenwood B; Chandramohan D; Valecha N
    Malar J; 2018 Jul; 17(1):246. PubMed ID: 29973212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children.
    Gomez EA; Jurado MH; Cambon N
    Acta Trop; 2003 Dec; 89(1):47-53. PubMed ID: 14636982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa.
    Massougbodji A; Kone M; Kinde-Gazard D; Same-Ekobo A; Cambon N; Mueller EA
    Trans R Soc Trop Med Hyg; 2002; 96(6):655-9. PubMed ID: 12625145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate.
    Rajahram GS; Barber BE; William T; Menon J; Anstey NM; Yeo TW
    Malar J; 2012 Aug; 11():284. PubMed ID: 22905799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance.
    Grigg MJ; William T; Piera KA; Rajahram GS; Jelip J; Aziz A; Menon J; Marfurt J; Price RN; Auburn S; Barber BE; Yeo TW; Anstey NM
    Malar J; 2018 Dec; 17(1):463. PubMed ID: 30526613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.
    Wootton DG; Opara H; Biagini GA; Kanjala MK; Duparc S; Kirby PL; Woessner M; Neate C; Nyirenda M; Blencowe H; Dube-Mbeye Q; Kanyok T; Ward S; Molyneux M; Dunyo S; Winstanley PA
    PLoS One; 2008 Mar; 3(3):e1779. PubMed ID: 18320064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Suntharasamai P; Charoenlarp P; Arnold K; Kyle D; Canfield C; Webster K
    Lancet; 1992 Apr; 339(8797):821-4. PubMed ID: 1347854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
    Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
    PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of an artesunate/mefloquine combination, (artequin) in the treatment of uncomplicated P. falciparum malaria in Kenya.
    Bhatt KM; Samia BM; Bhatt SM; Wasunna KM
    East Afr Med J; 2006 May; 83(5):236-42. PubMed ID: 16866217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.
    Price R; Luxemburger C; van Vugt M; Nosten F; Kham A; Simpson J; Looareesuwan S; Chongsuphajaisiddhi T; White NJ
    Trans R Soc Trop Med Hyg; 1998; 92(2):207-11. PubMed ID: 9764335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
    Ambler MT; Dubowitz LM; Arunjerdja R; Hla EP; Thwai KL; Viladpainguen J; Singhasivanon P; Luxemburger C; Nosten F; McGready R
    Malar J; 2009 Sep; 8():207. PubMed ID: 19725966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
    Valecha N; Savargaonkar D; Srivastava B; Rao BH; Tripathi SK; Gogtay N; Kochar SK; Kumar NB; Rajadhyaksha GC; Lakhani JD; Solanki BB; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Anvikar AR
    Malar J; 2016 Jan; 15():42. PubMed ID: 26818020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schizontocidal effects of oral artesunate on Plasmodium berghei in mice and P knowlesi in monkeys.
    Shi YL; Li GF; Zhao JH; Yang JD; Ding DB
    Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):755-8. PubMed ID: 10678113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of falciparum malaria to different antimalarials in Myanmar.
    Ejov MN; Tun T; Aung S; Sein K
    Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.